Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Agladze, Dodo
SYNPHENY-3, NCT05764239: Efficacy and Safety of SYNB1934 in Patients With PKU	Terminated	3	35	Canada, US, RoW	SYNB1934v1, Placebo	Synlogic	Phenylketonuria	03/24	03/24